Clinical Trials on AMS in Australia
Total 80 results
-
Biotronik AGCompletedLong Term Safety of the AMS 1.0Switzerland, Germany, Australia, Belgium, Netherlands
-
Eilean TherapeuticsRecruiting
-
University of Applied Sciences Upper AustriaKrankenhaus der Barmherzigen Schwestern RiedUnknown
-
Astellas Pharma Global Development, Inc.No longer availableAcute Myeloid Leukemia (AML) | FMS-like Tyrosine Kinase-3 (FLT3) MutationsAustralia, Italy, United Kingdom
-
CSL LimitedCompletedAcute Myeloid Leukemia (AML)Australia
-
Peter MacCallum Cancer Centre, AustraliaGlaxoSmithKline; Celgene CorporationCompletedMyelodysplastic Syndromes (MDS) | Acute Myeloid Leukaemia (AML)Australia
-
Eilean TherapeuticsNot yet recruiting
-
Center for Eye Research AustraliaRecruitingAge-related Macular Degeneration | Geographic Atrophy | Age Related Macular Degeneration | AMDAustralia
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedMyelodysplastic Syndrome (MDS) | Acute Myeloid Leukaemia (AML)France, Australia
-
Maxinovel Pty., Ltd.RecruitingAcute Myelogenous Leukemia (AML)Australia
-
University of BirminghamCompletedCancer | Pediatric ALL | Pediatric Solid Tumor | Pediatric AMLUnited Kingdom, Australia, Netherlands
-
Eisai Inc.TerminatedPediatric Acute Myelogenous Leukemia (AML)United States, Canada, Australia
-
GWT-TUD GmbHRecruiting
-
Novartis PharmaceuticalsTerminatedPhase 1 Study of LOP628 in Adult Patients With cKit-positive Solid Tumors and Acute Myeloid LeukemiaAML | cKIT-positive Solid TumorsBelgium, Spain, Australia, Netherlands
-
Medical University of ViennaFerring Arzneimittel GmbHRecruitingHypogonadism, Hypogonadotropic | AMH | Follicle CystAustria
-
Astellas Pharma Global Development, Inc.Active, not recruitingAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) MutationUnited States, Japan, Taiwan, Spain, Australia, Belgium, Canada, France, Germany, Italy, Korea, Republic of, Poland, United Kingdom
-
Ascentage Pharma Group Inc.RecruitingAML, AdultAustralia, United States
-
Medical University of ViennaUnknownAcute Coronary Syndrome (ACS)Austria
-
University of CalgaryThe George Institute for Global Health, AustraliaNot yet recruitingAcute Ischemic Stroke AIS | Stroke, Acute, Stroke Ischemic | Stroke AcuteCanada, Australia
-
Que OncologySyneos HealthCompletedVasomotor Symptoms (VMS)United States, New Zealand, Australia
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedMyelodysplastic Syndrome (MDS) | Acute Myeloid Leukaemia (AML)United States, Australia, France, Spain
-
Novartis PharmaceuticalsCompletedSubfoveal Choroidal Neovascularization CNV Secondary to Wet Age-related Macular Degeneration AMDAustralia
-
Novartis PharmaceuticalsCompletedAdvanced Triple Negative Breast Cancer (TNBC) With High TAMsFrance, Italy, Austria, Taiwan, United States, Spain, Australia, Korea, Republic of, Belgium, Germany, Hong Kong, Turkey
-
Medical University of ViennaUnknownCardiopulmonary Arrest With Successful Resuscitation | ACS - Acute Coronary Syndrome | Hypothermia, InducedAustria
-
Oraya Therapeutics, Inc.CompletedEye Diseases | Age-Related Macular Degeneration | Macular Degeneration | Retinal Diseases | AMD | Wet AMD | Wet Age-Related Macular DegenerationUnited Kingdom, Czech Republic, Austria, Germany, Italy
-
MedicureRecruitingPyridox(am)Ine 5'-Phosphate Oxidase DeficiencyUnited States, Australia
-
AbbVieGenentech, Inc.CompletedAML | Acute Myelogenous LeukemiaUnited States, Australia, Germany, Italy
-
Institut de Recherches Internationales ServierActive, not recruitingLeukemia, Myeloid, Acute | Untreated AML | Newly Diagnosed Acute Myeloid Leukemia (AML) | AML Arising From Myelodysplastic Syndrome (MDS)Spain, United States, France, Korea, Republic of, Taiwan, Australia, Canada, Germany, China, Italy, Austria, Czechia, Poland, Japan, United Kingdom, Russian Federation, Netherlands, Brazil, Israel, Mexico
-
Array BioPharmaCompletedAML | Advanced and Selected Solid Tumors | High Risk and Very High Risk MDSUnited States, Australia, Italy, Spain, France, Switzerland, United Kingdom
-
CelgeneAbbVieCompletedLeukemia, Myeloid, AcuteUnited States, Australia
-
Hoffmann-La RocheTerminatedLeukemia, Myeloid, AcuteItaly, Korea, Republic of, Belgium, Australia, United States, Canada, United Kingdom, Spain, Netherlands, France, Germany, New Zealand, Israel, Norway, Russian Federation, Switzerland, Austria, Finland, Panama
-
Cardiac Regeneration Technologies, LLCUnknownReduced Left Ventricular Function Defined as LVEF < 50% | Regional Left Ventricular Wall Motion AbnormalitiesAustria
-
Daiichi Sankyo, Inc.CompletedAMLUnited States, Korea, Republic of, Taiwan, United Kingdom, France, Australia, Spain, Italy, Canada, Singapore, Germany, Netherlands, Hong Kong, Belgium, Croatia, Czechia, Hungary, Poland, Serbia
-
VU University of AmsterdamLondon School of Hygiene and Tropical Medicine; Northumbria University; Region... and other collaboratorsCompletedTailored Implementation: Online ItFits-toolkit | Implementation as UsualNetherlands, Albania, Australia, Denmark, France, Germany, Italy, Kosovo, Spain
-
Kartos Therapeutics, Inc.TerminatedRelapsed or Refractory Acute Myeloid Leukemia (AML) | Acute Myeloid Leukemia (AML), Secondary to Myeloproliferative Neoplasms (MPN)United States, Spain, Korea, Republic of, Belgium, United Kingdom, Hungary, France, Germany, Israel, Australia, Italy, Poland
-
Senti BiosciencesRecruitingAML/MDS | CD33 Expressing Hematological Malignancies | FLT3 Expressing Hematological MalignanciesUnited States, Australia
-
AmgenTerminatedRelapsed/Refractory Acute Myeloid Leukemia (AML)United States, Korea, Republic of, Australia, Japan, Germany, Canada
-
AbbVieGenentech, Inc.TerminatedAcute Myelogenous Leukemia | Myelogenous Leukemia | Treatment Naive AMLUnited States, Australia, France, Germany
-
Medical University of ViennaImperial College London; Shirley Ryan AbilityLabEnrolling by invitation
-
Servier Affaires MédicalesRecruitingAcute Myeloid Leukemia (AML)Netherlands, Italy, Austria, France
-
Novartis PharmaceuticalsCompletedAML and High Risk MDSGermany, Italy, France, Netherlands, United States, Australia, Japan
-
Clavis PharmaCompletedAcute Myeloid Leukemia (AML)United States, Spain, France, Ireland, United Kingdom, Australia, Belgium, Canada, Germany, Italy, Norway, Poland, Romania
-
Hannover Medical SchoolCompletedAcute Myeloid Leukemia (AML)Austria, Czechia, Germany
-
University of UlmCompletedAcute Myeloid Leukemia (AML)Germany, Austria
-
Novartis PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia (AML) | High-risk Myelodysplastic Syndrome (MDS)Spain, Singapore, Australia, Germany, Italy, Finland, United States
-
Bioeq GmbHCompletedAge-related Macular Degeneration (AMD)France, Italy, Poland, Russian Federation, Spain, United Kingdom, Germany, Hungary, Ukraine, Austria, Czechia, Israel
-
Wave Life Sciences Ltd.TerminatedALS | FTDCanada, Belgium, New Zealand, Netherlands, Australia, Sweden, United Kingdom, Ireland
-
University of UlmCompletedAcute Myeloid Leukemia (AML)Germany, Austria
-
University of UlmCompletedAcute Myeloid Leukemia (AML)Germany, Austria
-
AbbVieGenentech, Inc.Active, not recruitingAcute Myeloid Leukemia (AML)United States, Australia, Austria, Belgium, Brazil, Canada, China, Croatia, Czechia, Denmark, Finland, France, Germany, Hungary, Israel, Italy, Japan, Korea, Republic of, Norway, Poland, Portugal, Puerto Rico, Russian Federation, South... and more